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Integrins are cell membrane receptors that are involved in essential physiological and 
serious pathological processes. Their main role is to ensure a closely regulated link between 
the extracellular matrix and the intracellular cytoskeletal network enabling cells to react to 
environmental stimuli. Complement receptor type 3 (CR3, αMβ2, CD11b/CD18) and type 4 
(CR4, αXβ2, CD11c/CD18) are members of the β2-integrin family expressed on most white 
blood cells. Both receptors bind multiple ligands like iC3b, ICAM, fibrinogen or LPS. β2-
integrins are accepted to play important roles in cellular adhesion, migration, phagocytosis, 
ECM rearrangement and inflammation. Several pathological conditions are linked to the 
impaired functions of these receptors.  
CR3 and CR4 are generally thought to mediate overlapping functions in monocytes, 
macrophages and dendritic cells, therefore the potential distinctive role of these receptors has 
not been investigated so far in satisfactory details. Lately it has become clear that a functional 
segregation has evolved between the two receptors regarding phagocytosis, cellular adhesion 
and podosome formation. In addition to their tasks on myeloid cells, the expression and 
function of CR3 and CR4 on lymphocytes have also gained interest recently. The picture is 
further complicated by the fact that while these β2-integrins are expressed by immune cells 
both in mice and humans, there are significant differences in their expression level, functions 
and the pathological consequences of genetic defects. Here we aim to summarize our current 
knowledge on CR3 and CR4 and highlight the functional differences between these receptors, 
involving their expression in myeloid and lymphoid cells of both men and mice. 
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1. Introduction 
The name “integrin” was given to point out that these integral cell membrane proteins 
ensure and maintain the integrity of the cytoskeletal-extracellular matrix (ECM) linkage [1]. 
Integrins are cell adhesion molecules that mediate cell-cell, cell-extracellular matrix, and cell-
pathogen interactions. They play critical roles in several immune phenomena where leukocyte 
trafficking and migration are involved, immunological synapses are formed, costimulation 
and phagocytosis take place. These hetero-dimeric glycoproteins consist of non-covalently 
coupled α and β chains. Integrins are ancestral receptors with early evolutional history, since 
both the α- and β- subunits can be found throughout the invertebrates from nematodes and 
fruit flies with remarkably well conserved sequences [2]. The integrin α and β subunits have 
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developed separately during evolution. In vertebrates, the molecules of the integrin family are 
composed of 18 α and 8 β subunits, that can assemble into 24 different heterodimeric 
receptors, each with different ligand-binding specificities and a diverse tissue distribution [3]. 
In mammals, nine of the 18 α subunits have the “inserted” or “αI” domain, forming the ligand 
recognition part of the receptor. Four αI domain containing integrins are collagen receptors, 
while the other five recognize E-cadherins, ICAMs or VCAMs and two of them (CR3, CR4) 
also bind plasma proteins such as fibrinogen, FactorX or component iC3b [4]. Both subunits, 
namely the α and the β chain have a large extracellular ligand binding region, a single 
transmembrane domain and a short cytoplasmic tail (Figure 1.). 
Recently the interest has been revived in the physiological and pathological role of 
CR3 and CR4, members of the β2-integrin family. Therefore we aim to give an overview on 
the structure, expression and diverse functions of these complement receptors on myeloid as 
well as lymphoid cells, suggesting a „division of labour” regarding their distinct roles on 
phagocytes. We also aim to highlight similarities and differences between the human and 
murine systems. 
 
2. Complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) 
Complement receptor type 3 (CR3) and type 4 (CR4) belong to the β2-integrin family 
(Figure 1.). As it will be discussed later in detail, they are expressed on all myeloid cells and 
certain lymphoid populations. The members of this family differ in their specificity and 
avidity to the different ligands. Associated with the common β2 chain (CD18) the four 
members of this family are the following: αLβ2 integrin (also known as LFA-1 or 
CD11a/CD18), αMβ2 integrin (Macrophage antigen-1 (Mac-1), complement receptor 3 (CR3 
or CD11b/CD18), αXβ2 integrin (p150,95, CD11c/CD18 or complement receptor 4 (CR4)), 
and αDβ2 integrin (CD11d/CD18) [5, 6]. Among the complement receptors binding various 
C3-fragments CR3 and CR4 have the unique property that their ligand binding is metal-ion 
dependent.  
CD11c is closely related to CD11b. It is 66% identical and 77% homologous to Mac-1 
over the β-propeller and the ligand-binding I domains. They bind similar ligands, including 
iC3b, ICAM and fibrinogen [7-10] via the metal-ion-dependent adhesion site (MIDAS) in the 
presence of a bivalent cation [11]. 
Sequence analysis of human cDNA encoding the α chains of CR3 and CR4 (165 and 
150 kD Mw) show a homology of 87% [12, 13], however these two integrins bind iC3b at 
distinct sites [14]. A greater structural difference is present in the cytoplasmic domains of 
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CR3 and CR4 α chains. The cytoplasmic tail of CR3 α (CD11b) has only 56% homology with 
the cytoplasmic domain of CR4 α (CD11c), and is less than two-third of its size. This suggests 
that functional differences between CR3 and CR4 may be derived from differences in their 
ability to associate with cytoplasmic components such as signalling or actin-binding proteins 
[13]. The common β-subunit extracellularly has an N-terminal I-like domain, a sandwich 
hybrid domain, a cysteine-rich PSI (plexin-semaphorin-integrin) domain, four EGF-like 
repeats (I-EGF1, -2, -3, -4) and a β-tail domain (βTD) (Figure 1.).  
CR3 and CR4 are named complement receptors as they readily interact with the iC3b 
fragment of the major component C3, generated during activation of the complement cascade 
(Figure 2.). However, as indicated in the figure these receptors interact with several additional 
structures, including ICAMs, the cell surface adhesion molecules, fibronectin, the adhesion 
molecule in extracellular matrix, and fibrinogen, the coagulation factor. 
The most studied functions of these receptors are phagocytosis, adherence and podosome 
formation. The earliest investigations identified CD11b/CD18 as a phagocytic β2-integrin 
specific to iC3b opsonized antigen, which was identical with the Mac-1 antigen expressed by 
mouse and human myeloid cells as well [13, 15]. While the main role of CR3 is to promote 
phagocytosis and cytotoxicity, it is also known to enhance the function of several effector 
molecules such as FcγR, uPAR, and CD14 [16]. It was demonstrated that association of 
macrophage cytoskeleton with CR3 and CR4 regulates receptor mobility and phagocytosis of 
iC3b-opsonized erythrocytes [13]. The α chain of CR4, CD11c is a cell surface marker which 
can be used to identify human myeloid cell subsets. 
 
 
3. Expression of CR3 and CR4  
Both CR3 and CR4 are widely expressed on most of the myeloid and lymphoid cell 
types both in men and mice, although the extent of their appearance varies. These receptors 
are usually upregulated on activated cells, irrespective of their naive expression status. In 
Table 1. we summarize available data and indicate the presence of these β2-family integrins 
using the plus/minus sign.  
 
 




 HUMAN MOUSE 
CR3 CR4 CR3 CR4 
MYELOID 
CELLS 
    
Monocyte + [17, 18] + [17, 18] + [19, 20] +/- [20, 21] 
Macrophage +++ [17, 22] +++ [17, 22] + [23] +/- [23-25] 
Dendritic cell +++ [17, 26] +++ [17, 26] +/- [27, 28]  +++ [24, 29] 
Neutrophil + [18, 30] + [18] + [31] +/- [32] 
LYMPHOID 
CELLS 
    
NK cell ++ [33, 34] +/- [35] +/- [20, 36] +/- [37] 
T cell +/-* [33, 38] +/-* [18, 39] +/-* [40, 41] +/-* [40, 42-45] 
B cell +/-* [33, 46-48] +/-* [46, 47, 49, 50] +/- [50, 51] +/- [50, 52] 
 
+/- appears on certain subpopulations 
+/-* appears on activated and leukemic cells  
 
 
3.1. Expression of CR3 and CR4 on human myeloid cells 
These integrins can be found on all myeloid cells, namely neutrophil granulocytes, 
monocytes, macrophages and dendritic cells [17, 18, 30]. An important progress has been 
made recently, when the absolute number of these receptors has been assessed on human 
monocytes, monocyte-derived macrophages (MDM), monocyte-derived dendritic cells 
(MDDC) [17] and neutrophils (Table 2.). Data shown reveals that the expression level of the 
two receptors varies between cell types. Comparing the relative number of CR3 and CR4 on 
the same cell types there is a strong shift in favour of CR3 in the case of monocytes and 
neutrophils, whereas on MDMs and MDDCs the CD11b:CD11c ratio is close to 1:1. The 
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notable differences in receptor number most probably contribute to the functional diversity 
observed in the case of these cell types. Furthermore, the availability of ligand epitopes may 
also influence the competition between these receptors, determining the outcome of the 
interactions.  
 
Table 2. The average number of CR3 and CR4 expressed by normal human myeloid 
cells (receptor number x103 /cell) 
 
 Monocytes MDM MDDC PMN* 
CR3 (CD11b/CD18) 50±8 310±62 247±21 47±6 
CR4 (CD11c/CD18) 7±3 185±40 204±25 3,5±2 
     
Ratio of  
CD11b and CD11c  
7,1 1,7 1,2 13,4 
*Personal communication by Dr. Noémi Sándor.   
 
3.2. Expression of CR3 and CR4 on human lymphoid cells 
 
Among lymphoid cells of healthy donors all NK cells are known to express CD11b, while 
CD11c can be found only on a subset of these leukocytes [33-35]. Approximately 10% of 
human peripheral T lymphocytes - mainly CD8+ cells -, express CD11b, while CD4+ T cells 
become positive only after activation. The majority of CD11b+ T cells express CD56, too 
[33]. T cells – similarly to NK cells - contain preformed CR3, which is transferred rapidly to 
the surface following exposure to phorbol ester [33, 38]. Stimulation of T cells yielded up to 
28% CD11b+ T cells [38]. CD11c is not expressed on peripheral T lymphocytes, but it 
appears on both CD4+ and CD8+ CTL clones [18, 39]. 
The picture is more complex in the case of B lymphocytes. Muto et al. found that 
approximately 20% of peripheral blood B cells express CR3 [33]. In contrast to this Postigo 
and colleagues found no significant expression of CD11b on tonsillar or peripheral B 
lymphocytes, even after activation [46], similarly to Uzonyi et al. [47] In contrast to this, 
Rothstein et al. detected CD11b+ on a small subset of B-1 cells [48]. In the case of chronic 
lymphocytic leukemia (CLL), B cells express diverse levels of CD11b, varying widely among 
patients [47]. Regarding the appearance of CD11c on human B lymphocytes there are only 
sporadic and inconsistent data available. In 1990 Wormsley et al. found two subsets of 
peripheral B cells expressing CD11c [49], but Postigo et al. found no significant expression of 
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this integrin on non-stimulated tonsillar or peripheral B lymphocytes. After activation with 
PMA for three days however, most B cells became CD11c+ [46]. Recently Rubtsov et al. 
defined a CD11c+ population of B cells (called Age Associated B Cells, ABCs) which is 
represented in low numbers in the blood of healthy donors but is expanded in older women 
with autoimmune diseases [50]. Furthermore, CD11c was found clearly expressed by 
leukemic B cells, although to various extent [47]. 
  
3.3. Expression of CR3 and CR4 on mouse myeloid cells 
CD11b is unequivocally expressed on mouse monocytes [19, 20] similarly to 
macrophages [23]. This is in contrast to CD11c, which is not present on monocytes newly 
released from the bone marrow, however appears upon maturation of the cells [21]. 
According to Helft et al. CD11c is expressed by mouse macrophaghes [24], and the 
expression increases in multinucleated giant cells [23], while Gorgani et al. showed that 
mouse residential peritoneal macrophages lack CD11c [25].  
Mouse DC are highly positive for CD11c, therefore this molecule is often used to 
identify these cells. On dendritic cells (DC) CD11b is expressed in different levels, defining 
CD11bhigh and CD11blow or CD11b- subsets. CD11b is accepted as a marker of myeloid DC in 
mice [27, 28]. Interestingly however, mouse DC down-regulate cell surface CD11c upon 
activation in sharp contrast to human DC [29, 53]. 
Mouse neutrophil granulocytes also express CD11b, which increases after activation 
[31]. According to Matsushima et al. these cells can also acquire a CD11c positive phenotype 
in certain conditions [32]. 
 
3.4. Expression of CR3 and CR4 on mouse lymphoid cells 
 
According to Chiossone et al. murine NK cells have a CD11blow phenotype in the 
beginning of their differentiation and become CD11bhigh when fully developed  [36].In 
contrast to this Sunderkotter et al. showed that the CD11bhigh population of peripheral blood 
contain no NK cells [20]. Regarding the expression of CD11c, a distinct subset of NK cells 
was found to be positive, particularly in the liver [37]. 
In the case of murine B cells, Ghosn et al. described, that during ontogeny, CD11b- B-
1 cells precede CD11b+ B-1 cells [51]. The CD11c+, age associated B cells were found to 
express CD11b, too [50]. Recently Naradikian and colleagues demonstrated that some 
memory B cells also express CD11c due to a unique cytokine milieu and/or infections [52]. 
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With regard to murine T cells CD11b expression correlates with their level of activity [41] 
and is often co-expressed with CD11c on activated T cells [42, 43, 45]. A number of studies 
revealed, that only activated T cells express CD11c [42-45]. A specific cell type, called TDC 
also expresses CD11b along with CD11c [40]. 
 
4. Integrin activation and signalling 
Generally, integrins are present on the cell membrane in an inactive state, which 
allows free circulation of leukocytes in blood vessels. They undergo conformational changes 
induced by intracellular and extracellular stimuli following inside-out and outside-in 
signalling which leads to the separation of the α and β cytoplasmic tails. This activation is 
achieved by cytosolic proteins connecting integrins to the actin cytoskeleton [54].  
A major breakthrough in integrin research was brought by the explanation of the 
switchblade-like model of integrin activation based on electron microscopic and 
crystallization studies [55, 56]. The three possible conformations of β2-integrins are the 
following: i/ bent, inactive, ii/ extended with intermediate affinity and iii/ extended, open 
conformation, with high affinity [55, 57, 58] (Fig. 1.). In the inactive form both subunits are 
bent, positioning the I domain near the cell membrane. The extension of the integrin legs 
enables a swing-out movement for the PSI and hybrid domains, inducing the conformational 
change in the I domain required for a high affinity, open state [59]. It has become clear by 
now that the structure of integrins is functionally relevant, therefore the access of the specific 
monoclonal antibodies –such as mAb KIM127 or mAb 24 for CD18 and CBRM1/5 for 
CD11b such as mAb KIM127, mAb 24 – makes possible to differentiate the conformation 
dependent functions [60, 61]. 
During the past few years several details of the molecular mechanisms of integrin 
activation have been elucidated. The small GTPase Rap1 (Ras-proximate-1), was shown to 
participate in the talin dependent inside-out activation of many different integrins, including 
β2-integrins [62, 63]. At least two effectors of Rap1 have been found: RapL (Rap-ligand) and 
RIAM (Rap1-interacting adaptor molecule). RAPL acts on the α subunit, while RIAM is 
proposed to stimulate the binding of talin to the cytoplasmic tail of the β-subunits [64, 65]. 
Macrophages and neutrophils from RIAM deficient mice show disrupted β2-integrin 
dependent adhesion and spreading [66]. Using the human THP-1 monocytic cell line, Lim et 
al. found, that siRNA silencing of RIAM did not impair phagocytosis and spreading [67]. 
Later it has been shown that the Regulator of G-Protein Signalling-14 (RGS14) plays a role in 
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the activation of CR3 during phagocytosis in the murine J774.A1 cell line [68]. However, 
Medraño-Fernández et al. revealed, that RIAM is important for complement mediated 
phagocytosis in the case of HL-60 and THP-1 cell lines and human monocyte derived 
macrophages [69]. Data obtained from the KO mice models suggest, that the effect of RIAM 
might be β2-specific, as the function of platelet αIIbβ3 integrin [70] and β1 integrins 
expressed by PMNs [66] is not disrupted in these mice. Additionally, talin deficient mice 
show a more severe phenotype compared to RIAM KO mice [66], underlining that the 
absence of talin affects all integrins, but the absence of RIAM does not.  
The extracellular binding of ligands to activated integrins stimulates outside-in 
signalling pathways, including recruitment of multiple structural (vinculin, paxillin and actin) 
and signalling (p130Cas, FAK and Rho GTPases) proteins. These processes result in 
rearrangement of the actin cytoskeleton, and generation of adhesion structures promoting 
various biological processes including cellular adherence, migration and phagocytosis.  
Little is known about the molecules interacting with the CD11b and CD11c chains, 
however it has been shown that the kinetics of activation of αLβ2 and αMβ2 integrins are 
different and the specific signals derived from the integrin α tail is assigned to distinct 
cytoplasmic molecules [71]. 
A remarkable property of CR3 is its ability to contribute to the function of other immune 
receptors like FcγRIIA, FcγRIIIB, CD14, β1-integrins, Dectin-1, and TLRs. These interactions 




5.  Function of CR3 and CR4 on myeloid cells  
 
In this section we review the present knowledge on the function of CR3 and CR4 in 
different cell types of humans and mice. In Table 3. available information is summarized, 
which is followed by subsections with more detailed description of the several roles played by 
these β2-integrins on a wide variety of cell types. 
 
 






Role in human systems Role in mouse systems 
CR3 Mo adherence to fibrinogen [17] and 
endothelium [73], phagocytosis [74-
78] 
adhesion to endothelium [79] 
phagocytosis [20] 
MF podosome formation [78] 
phagocytosis [78, 80, 81] 
adherence [82], opsonic [83] and non-
opsonic [76, 84, 85] phagocytosis 
DC podosome formation [78, 86] 
phagocytosis [53, 78, 87] 
phagocytosis of apoptotic cells [88] 
PMN chemotaxis [89], adherence [90] 
opsonic [78, 91] and non-opsonic 
[92, 93] phagocytosis 
adherence, degranulation [94] 
phagocytosis [95] 
NK enhancement of cytotoxicity [96-98] enhancement of cytotoxicity [99] 
T cell inhibition of proliferation and IL-2 
release [38] 
homing of CD8+ T cells [100, 101] 
amelioration of ICG [102] 
involvement in T cell development 
[103], boosting EAE [104] 
B cell migration [105] 
spreading of CLL B cells [47] 
 
negative regulation of BCR signalling 
[106] 
regulation of Ig responses [107] 
amelioration of EAH [108]  
CR4 Mo adherence to fibrinogen [17] 
migration [39] 
 n. d. 
MF podosome formation [78] adherence 
to fibrinogen [17] 
phagocytosis [75, 77, 91, 109] 
phagocytosis [95] 
DC podosome formation [78, 86] 
adherence to fibrinogen [17] 
role in uptake [87] 
phagocytosis of apoptotic cells [110] 
PMN adhesion to endothelium [73] 
enhancement of anti-bacterial 
activity [111] 
n. d. 
NK n. d. n. d. 
T cell cell-mediated cytolysis by a subset 
of CD8+ cells [39] 
boosting EAE [104, 112] 
B cell proliferation [46] 
attachment to fibrinogen [46] 
spreading of CLL B cells [47] 
 n. d. 
Mo: monocyte; MF: macrophage; DC: dendritic cell; PMN: polymorphonuclear cell; NK: 




5.1. Involvement of CR3 and CR4 in phagocytosis 
Well accepted roles of CR3 and CR4 are to mediate cellular adhesion and 
phagocytosis of pathogen microbes, tumor- and apoptotic cells. In phagocytosis both 
receptors are clearly involved, as it had been shown by transfection of non-phagocytic CHO 
cells by CR3 and CR4 [113]. However, depending on the level of expression and the possibly 
different signalling partners, their participation in phagocytosis varies among cell types. A 
study carried out in whole blood showed that the CD14high CD16+ subset of monocytes, 
expressing the highest levels of CD11c and activated CD11b, phagocytosed Plasmodium 
falciparum infected erythrocytes more efficiently than other monocyte subsets. Phagocytosis 
could be inhibited on these monocytes more effectively with anti-CD11b than with CD11c 
blocking antibodies [74]. Further experiments employing monocytes also proved the 
dominant role of CR3 in the phagocytosis of Mycobacterium leprae [75] and Borrelia 
burgdorferi [76] and no significant contribution of CR4 to the CR3 mediated uptake of 
Mycobacterium tuberculosis [77] and Staphylococcus aureus [78] was found.  
Downregulation of CR3 and CR4 by cytomegalovirus infection in human 
macrophages reduced their phagocytic capacity for Candida albicans, however the extent of 
contribution of the two receptors was not clarified [22]. While CR3 clearly mediates 
phagocytosis [80] and the phagocytic removal of desyalinated neurits by macrophages [81], 
CR4 is shown to be the major receptor mediating the uptake of Mycobacterium tuberculosis 
by alveolar macrophages [77]. Experimental data show that on MDM both CR3 and CR4 are 
involved in binding and/or phagocytosis of opsonised Cryprococcus neoformans [109], 
Mycobacterium leprae [114] and Francisella tularensis [91]. These studies however, do not 
clearly differentiate between uptake and digestion of the pathogens. Recently we examined 
these two sequential processes separately using S. aureus labelled with the pH sensitive 
pHrodo Green dye, which becomes highly fluorescent only in the acidic milieu of 
phagolysosomes, indicating the digestion of bacterial particles. Using this method we proved 
that in MDM only CR3 takes part in the ingestion of iC3b opsonized Staphylococcus aureus, 
while CR4 participates only in the surface binding of the pathogen [53, 78]. According to our 
studies human DC use exclusively CR3 as a phagocytic receptor and CR4 does not take part 
in this process [53, 78]. Pathogens can exploit CR3 to evade the host DC, like in the case of 
HIV, where complement-opsonized particles were shown to enhance infection [115]. In 
contrast to our findings suggesting a divergent function of CR3 and CR4 on human DC, Ben 
Nasr et al. demonstrated that blocking either CR3 or CR4 inhibited the phagocytosis of 
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opsonized, live Francisella tularensis [87]. This contradiction might be due to differences in 
the pathogens employed in the experiments and the capacity of live Francisella tularensis to 
utilize CR4 as well to get into the host cells. 
Neutrophils use CR3 but not CR4 for serum-mediated phagocytosis of Francisella 
tularensis [91] and iC3b opsonized S. aureus [78]. In the case of human neutrophils CR3 is 
also involved in nonopsonic phagocytosis e.g. of Salmonella enterica [92] or Mycobacterium 
kansasii [93].  
The role of CR3 in the process of phagocytosis by mouse macrophages has been 
demonstrated by several authors. Pan et al. showed that CR3 mediates the uptake of 
complement opsonized Trypanosoma congolense [83], while others demonstrated the role of 
this integrin in the uptake of non-opsonized Histoplasma capsulatum [84], Porphyromonas 
gingivalis [85] and Borellia burgdorferi [76]. The participation of CR4 in phagocytosis by 
murine macrophages is debated. Milde et al. showed, that in macrophage derived 
multinucleated giant cells CR4 is rather involved in adhesion, while phagocytosis of 
opsonized particles is mediated by CR3 [23]. By contrast, according to Jawhara et al. CR4 is 
the dominant receptor in phagocytosis and killing of Candida albicans or Escherichia coli by 
mouse macrophages [95]. However, this could be explained by the fact that involvement of 
complement receptors in phagocytosis may be different not only among various species and 
cell types, but can depend on the serotype of bacteria. For instance human MDM recognize 
Salmonella typhimurium but not S. typhi via CR3. By contrast, murine macrophages bind S. 
typhi through CR3 but not S.typhimurium [116]. 
While mainly CR3 is involved in the phagocytosis of apoptotic cells by mouse BMDC 
[88] and marginal zone DC, CR4 was also shown to contribute to this process, however, to a 
lesser extent. The higher level of CD11b expression on splenic DC correlates with a higher 
phagocytic capacity for apoptotic cells in the presence of complement factors [110]. 
Nevertheless, the phagocytosis of Porphyromonas gingivalis was not dependent on CR3 by 
BMDC [117], whereas the uptake of the same pathogen is mediated by CR3 in macrophages 
[85]. 
Challenging PMN isolated from wild type and CR3 or CR4 deficient mice with 
Candida albicans showed that only CD11b-deficient PMN had reduced antifungal activity, 
lack of CD11c did not affect their phagocytic capacity [95]. These data suggest that mouse 
neutrophils use only CR3 but not CR4 in phagocytosis, similarly to the human cells. 
The uptake of apoptotic cells is a physiological process that occurs without the 
induction of inflammation. CR3 was shown to induce an anti-inflammatory response, 
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contributing to the maintenance of immune tolerance [118, 119]. The ligation of CR3 by iC3b 
opsonized apoptotic cells down-regulates costimulatory molecule and MHC-II expression 
[120] and induce a tolerogenic phenotype in dendritic cells [121]. 
 
5.2. Involvement of CR3 and CR4 in cellular adherence and podosome 
formation 
In addition to promote phagocytosis, CR3 and CR4 are known for long to mediate cell 
adhesion, spreading and migration through the establishment of cell-cell and cell-extracellular 
matrix connections. In most of the studies the functions of LFA-1 and CR3 – but not that of 
CR4 - are investigated in detail, moreover the commonly used mouse models are either 
CD11b- or CD18-deficient [31, 94]. Nevertheless, studies on human granulocytes and 
monocytes showed that LFA-1, CR3 and CR4 all contribute differently to endothelial 
adhesion. It has been demonstrated that depending on the cell type and the stimuli used, the 
participation of these receptors in adhesion may be different. The adherence of unstimulated 
monocytes to endothelial cells was mostly dependent on LFA-1, but PMA-induced 
granulocyte adhesion was only inhibited by antibodies against CR3 [73, 90]. Thacker & 
Retzinger showed that human MDDC bind to fibrinogen and secrete cytokines in a CD18-
dependent manner, however, they did not identify the β2-integrin involved [122]. 
Georgakopoulos et al. showed, that CR3 and CR4 contribute differently to adhesion on 
fibrinogen and their participation depends on the experimental conditions. Whereas freshly 
isolated monocytes stimulated with GM-CSF and fMLP utilized CD11b, cells cultured in 
medium supplemented with normal human serum prior to stimulation used both CD11b and 
CD11c for adhesion [123].  
Recently we set out to dissect the role of CR3 and CR4 in adhesion, employing human 
MDM and MDDC along with antibodies specific to the ligand binding site of the receptors. 
We proved that CR4 is the main receptor that mediates adhesion to fibrinogen, and blocking 
of CR4 decreased the force of adhesion on both cell types. Studying the spreading of 
macrophages we found that anti-CR4 also inhibited this function of these human cells. [17, 
124, 125]. Immune cells of the monocytic lineage use specific adhesive structures for cell 
migration, called podosomes. These actin rich structures are known to mediate short-lived 
adhesion spots that are formed and quickly remodelled during migration. Cell movement can 
be achieved with podosome disassembly at the uropod and formation at the leading edge 
[126]. These structures have an F-actin core surrounded by an adhesion ring, and can be found 
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on the contact surface of adherent cells [127-129]. The importance of β2-integrins in 
podosome formation and podosome mediated adhesion has been proven, but the individual 
role of these receptors had not been studied so far. Burns et al. found, that β2- integrins are 
specifically recruited to podosomes in human MDDCs on a fibronectin surface (a ligand for 
both β1- and β2-integrins), whereas β1- integrins show a disperse distribution [86]. In a β2-
integrin-null mouse model, Gawden-Bone et al. showed that in the absence of β2-integrins 
podosome assembly is disrupted [130]. Our group demonstrated recently that both CR3 and 
CR4 are located in the adhesion ring of podosomes in human MDMs and MDDCs attached to 
fibrinogen [78], suggesting that both receptors might be equally important for the formation 
of these adhesive structures. 
 
5.3 Pathological implications of CR3 and CR4 
There are pathological conditions linked to the impairment of cell attachment, 
migration and the formation of adhesive structures. The most severe of these, leukocyte 
adhesion deficiency (LAD) is a rare autosomal recessive human disorder characterized by 
recurrent bacterial and fungal infections and impaired wound healing [131]. This deficiency 
has several types, with various mutations affecting certain steps of the cellular adhesion 
cascade [132]. The key role of β2 integrins against microbial antigens is illustrated by patients 
with the type 1 LAD syndrome (LAD-I), which is caused by a variety of mutations in the 
ITGB2 gene, coding the β2-integrin subunit [133]. Patients having the mutated gene show 
reduced expression of all β2 -integrins, including LFA-1, CR3 and CR4 [131]. Neutrophils 
and mononuclear cells from LAD-I patients fail to adhere and migrate to the site of 
inflammation, and show defects in the phagocytosis of complement opsonized particles [134-
137].  
In the context of impaired immune cell motility the Wiskott–Aldrich Syndrome 
(WAS) should be mentioned, which is an X-linked complex human disorder caused by the 
lack of Wiskott–Aldrich Syndrome protein (WASP). WASP is a regulator of actin 
polymerisation and its presence is restricted to the haematopoietic lineage [138]. As the 
assembly and disassembly of podosomes is a dynamic process mediated by fast actin 
reorganisation, it is not surprising, that WASP is required for their formation in myeloid cells 
[139, 140], and the integrins forming their adhesion rings also require a cytoskeletal 
connection [141]. Podosome assembly [139, 140, 142] and the clustering of β2-integrins [86, 
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143] are disrupted in PMN, macrophages and DC of WAS patients and WASP-deficient mice 
[142]. 
CR3 was also shown to have a role in the pathogenesis of systemic lupus 
erythematosus (SLE). A single nucleotide polymorphism in the CD11b chain (rs1143679) is 
identified as a risk factor in SLE [144]. The expression of cell surface CD11b is not altered, 
and the receptor can go under activation induced conformational changes [6, 145]. Reduced 
iC3b mediated phagocytosis and adhesion was observed in monocytes and monocyte-derived 
macrophages isolated from patients with this mutation [145, 146]. 
 
6. Function of CR3 and CR4 on lymphoid cells 
 
As of now, the function of CD11b and CD11c on lymphoid cells has scarcely been 
studied, and available data are not always concordant. However, interest in this topic is 
increasing and summarizing data presently available might be useful to boost further 
investigations. Here we will discuss results obtained in human and mouse systems 
simultaneously. 
 
6.1. B cells 
Regarding human cells, in 2005 Kawai et al. characterised a CD11b-expressing 
peripheral blood memory B cell population and demonstrated the extensive contribution of 
CD11b to the high migratory potential of these cells [105]. Using a trans well assay they 
observed a significantly reduced number of migrating B lymphocytes when CD11b blocking 
antibody was added to the system. A few years later the same group also showed that 
epigallocatechin gallate (EGCG), the major component of tea catechin exerted its anti-allergic 
and anti-inflammatory effects by inhibiting the CD11b-induced adhesion and migration of 
peripheral blood B cells [147]. Besides this, a CD11b+ population of human B cells with high 
IL-10 producing capacity and T cell regulator property was identified by Griffin et al. [148]. 
The direct participation of CD11b in the observed regulatory functions however, was not 
investigated in these studies. 
The role of CD11c in the activation and adhesion of PMA stimulated human B 
lymphocytes was demonstrated by Postigo et al., who revealed that the ligation of CD11c 




The appearance of CD11b and CD11c has also been reported in various human B cell 
malignancies [149, 150]. It is assumed that this might lead to the elevated adhesive and 
migratory behaviour of leukemic B cells to retain in the bone marrow or reach different 
organs effectively. Recently, our group also showed that both CD11b and CD11c take part in 
the spreading of CpG-activated CLL B cells on fibrinogen [47]. Correlation between the 
expression of CD11b/CD11c and malignant disease progression has been suggested by Legac 
et al. [151], but clinical studies also produced contradictory data [152]. 
In a mouse model, Ding et al. showed that CD11b negatively regulates BCR signalling 
via the Lyn-CD22-SHP-1 pathway to maintain autoreactive B cell tolerance, since CD11b-
KO autoreactive B cells exhibit enhanced proliferation, activation, survival and autoantibody 
production [106]. These authors also suggest that this might have a connection with the 
pathogenesis of SLE, given the known association of the rs1143679 CD11b gene variation 
and disease susceptibility [153, 154]. Besides, it was demonstrated by Rubtsov et al. that a 
population of CD11b and CD11c double positive B cells – called age-associated B cells 
(ABCs) – might have a direct role in autoantibody production and the development of 
autoimmunity. This special population of B cells was found not only in mice, but in the 
peripheral blood of some elderly women with autoimmune disease [50]. In a recently 
published study, the activation induced expression of CD11b on mouse B-2 B cells seemed to 
be required for an adequate antibody response. Namely, CD11b regulated the 
immunoglobulin heavy chain class switch recombination and the somatic hyper mutation of 
B-2 B cells via the NF-κβ dependent induction of the activation-induced cytidine deaminase 
(AID) [107]. The role of CD11b was also studied by Liu et al., who characterized a 
population of mouse B cells expressing CR3 which can suppress the severity of Experimental 
Autoimmune Hepatitis (EAH) through the inhibition of CD4+ T cell responses. They also 
proved that CD11b is necessary for this regulatory function [108]. 
  
6.2. T cells 
In the case of human T cells several studies showed that their subpopulations with 
killer properties acquire CD11b [33, 155]. The direct link between CR3 expression on T cells 
and their cytotoxicity however, has not been evidenced so far. Furthermore, it was also 
demonstrated that CD11b mediates inhibition on anti-CD3-induced T cell proliferation and 
IL-2 release [38] and facilitates homing of CD8+ T cells to sites of inflammation [100, 101].  
The exact role of CD11c in human T lymphocyte functions is still unclear, but 
correlation with high migratory properties and a greater IFN-γ secretory potential has been 
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described [45]. Besides this Keizer et al. found direct evidence of CD11c mediated 
cytotoxicity of CD8+ T cell clones [39]. 
In knock out mice CD11b seemed to be protective against complement-mediated 
immune complex glomerulonephritis (ICG) via diminishing the number of infiltrating, 
reactive CD4+ T cells to the inflamed kidney [102]. Moreover, in mice with the same genetic 
background decreased proliferation of T cells stimulated with the commonly used 
superantigen, staphylococcal enterotoxin was observed, probably due to phenotypic 
abnormalities. This result suggests that CD11b is required for the appropriate development of 
mouse T cells [103]. 
CD11c in mice appears on some subpopulations of CD8+ regulatory T cells, which 
participate in the amelioration of collagen-induced arthritis (CIA) [156], experimental 
autoimmune uveoretinitis (EAU) [157] and colitis [44], presumably through IFN-γ mediated 
suppression of CD4+ T cell induced proinflammatory responses. The effector function of 
CD11c+ CD8+ T cells in viral [42] and parasitic [158] infection models is also demonstrated. 
However, the direct contribution of CD11c to these protective mechanisms has not yet been 
revealed. 
Results from adoptive transfer experiments and T cell proliferation assays in β2-
integrin deficient mice indicate that the expression of both CD11b and CD11c on mouse T 
lymphocyte subsets is critical in the development of experimental autoimmune 
encephalomyelitis (EAE), the animal model for multiple sclerosis [104]. 
 
6.3. NK cells 
Regarding human NK cells, early results indicated that CD11b was essential in the C3-
fragment mediated enhancement of cytotoxicity by promoting the interaction of complement-
coated target cells with the lytic effector NK cells [96]. The exact function of CD11c on 
human NK cells has not yet been clarified, however a differentiated CD11c+ NK cell 
population with increased IFN-γ producing capacity, tumor cell cytotoxicity and γδ T cell 
proliferation inducing property was characterized recently [159]. In mice, subsets of CD11c+ 
NK cells were identified as the main IFN-γ producers at the sites of infection [37, 160] and in 







The recognition of complement opsonized, iC3b-labelled targets by the structurally 
very similar leukocyte integrins M2 (CR3) and X2 (CR4) is essential for various 
effector functions, including phagocytosis. Since the early description of Mac-1 (CR3), as a 
phagocytic β2-integrin binding to iC3b opsonized antigen, and the description of p150,95 
(CR4) as a molecule with similar properties; several studies have indicated, that in spite of the 
undoubtedly overlapping structures and functions, a „division of labour” exists between the 
two receptors. CR3 and CR4 play critical roles in diverse immune phenomena where 
leukocyte phagocytosis takes place, trafficking and migration are involved, immunological 
synapses are formed and co-stimulation is implemented. Because of the significance of these 
β2-type integrin receptors, research in the field is intense and covers a wide range of topics. 
Studies on their expression and function both in human and mouse leukocytes in healthy, 
diseased and genetically modified subjects, as well as examination of the molecular details of 
their working are expanding in recent years. 
From an evolutionary point of view it looks wasteful to express two different receptors 
for the same task by one cell. Moreover, CR3 and CR4 bind to different regions of iC3b and 
the intracellular domain of CD11b and CD11c differ in length and amino acid sequence, 
which suggest differences in their functions. Regarding myeloid cells, recent data highlight 
clearly separable roles of CR3 and CR4, while in the case of lymphoid cells their distinct task 
has not yet been systematically investigated. It will be important to see whether we can find a 
similar “separation of duties” in the case of lymphocytes and NK cells, too.  
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Legend to Figures 
 
Fig. 1. Domain structure and conformational changes of β2-integrins. 
The ligand binding affinity of integrins is regulated by activation dependent conformational 
changes. Integrins can convert between an inactive bent and an activated extended 
conformation. Both subunits are bent in the inactive form, positioning the head domains near 
the cell membrane. Inside-out signalling results in the extended conformation, orienting the I 
domain away from the membrane. Ligand binding to the activated integrin triggers the 
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outside-in signalling pathway, recruiting various cytosolic activator proteins. The combination 
of a lateral force exerted by the actin cytoskeleton and the resistance provided by the bound 
ligand stabilizes the high affinity, open state.  
 
Fig.2. Generation of complement-derived ligand for CR3 and CR4  
The complement cascade activated by either of the three pathways (classical, lectin-dependent 
and alternative) leads to the activation of the central component, C3. The larger cleavage 
product C3b, can be further processed to generate iC3b, which remains covalently attached to 
the activating surface (eg. microbes, apoptotic cells, immune complexes) and binds to 
complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18). Additional ligands of 
these β2-type integrin family receptors are listed in the ellipsoid with a grey background. 
 
Fig.3. CR3 and CR4 mediated functions in human myeloid cells 
CR3 is the dominant receptor to mediate uptake and/or digestion of iC3b-opsonized antigen 
by human Mo, MDM, MDDC and PMN, while the prominent role of CR4 on MDM and 
MDC has been demonstrated in the process of adherence to fibrinogen. For podosome 
formation CR3 and CR4 participate equally in MDM and MDDC. For further information 
please consult Table 3. 
 
Fig.4. Involvement of CR3 and CR4 in various functions of T and B lymphocytes and 
NK cell in mice and men.  
In the figure only those functions are shown where involvement of CR3 and/or CR4 had been 
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